insights_auto
Outlook: 59.6% bullish·2.1% bearish
Go to analysischevron_right
REGN:NASDAQ
Regeneron Pharmaceuticals Inc
$726.47
arrow_downward
-1.19%(-8.73) 1D
$727.25
arrow_upward
+0.11% (+0.78)bedtimeAfter hours
Closed: Oct 5, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REGN...
Open
$734.36
High
$736.42
Low
$722.02
Mkt. cap
74.79B
Avg. vol.
724.44K
Volume
53.00
Dividend
0.52%
Quarterly dividend
$0.94
Ex-dividend date
Aug 18, 2026
P/E ratio
17.96
52-wk high
$859.34
52-wk low
$541.00
EPS
$40.45
Beta
0.16
Shares outstanding
101.14M
No. of employees
15K
Open
$734.36
High
$736.42
Low
$722.02
Mkt. cap
74.79B
Avg. vol.
724.44K
Volume
53.00
Dividend
0.52%
Quarterly dividend
$0.94
Ex-dividend date
Aug 18, 2026
P/E ratio
17.96
52-wk high
$859.34
52-wk low
$541.00
EPS
$40.45
Beta
0.16
Shares outstanding
101.14M
No. of employees
15K
News stories
From web sources and news partners
News Corp
·
13 hours ago
Regeneron Pharmaceuticals Inc. stock underperforms Monday when compared to competitors
AD HOC NEWS
·
13 hours ago
Sanofi stock falls 1.16 percent as pipeline deal draws scrutiny
Benzinga
·
15 hours ago
Nasdaq 100 Records Have Rarely Been This Narrow, 55 Stocks Are Still Below 50-Day Average
AD HOC NEWS
·
20 hours ago
Seeking Alpha downgrades Regeneron stock to Hold
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
About Regeneron Pharmaceuticals Inc
CEOLeonard Schleifer
Employees15.3K
Founded1988
HeadquartersTarrytown, New York, United States
SectorBiotechnology
Websiteregeneron.com